Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial - Wikidata - awgldk - TriplyDB

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

http://www.wikidata.org/entity/Q28361953

about

Pleiotropic effects of statins in the diseases of the liver Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression Exploiting the critical perioperative period to improve long-term cancer outcomes Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer mTORC2 is required for proliferation and survival of TSC2-null cells.Statin use and risk of liver cancer: an update meta-analysis.Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck Survivin and escaping in therapy-induced cellular senescence.Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy Statins and prostate cancer risk: a case-control study.MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase Effects of statins on the risk of hepatocellular carcinoma Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study.Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.Statin-Based Palliative Therapy for Hepatocellular Carcinoma Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients.Anticancer activity of the cholesterol exporter ABCA1 gene.Hepatocellular carcinoma: therapy and prevention.Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.Statin use and cancer risk: an epidemiologic review.Emerging drugs for hepatocellular carcinoma.Drug insight: statins and gastrointestinal cancer.The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer Effect of pravastatin on the survival of patients with advanced gastric cancer.Candidate cancer-targeting agents identified by expression-profiling arrays.Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells.The prince and the pauper. A tale of anticancer targeted agents.Safety of statin therapy in patients with preexisting liver disease.Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.

P2860

Q26741176-D2BC38E5-B55A-436A-8807-2B081238C8A2 Q28394917-1F315AE4-4987-4A6E-9154-2202D25C4C63 Q28540910-7676A0AE-04F9-4ACA-8EF2-C142C2F03388 Q30241078-A31F134C-F412-4D84-A729-103DF0131EAA Q30456087-0A1D22A1-9130-4B3F-9865-EEDBCEFBA9D4 Q33266698-0066F4E2-D391-48ED-AC4F-4CAD4140022F Q33542856-E7AE5F3B-3111-4F1D-9DE6-5802EACEAA00 Q33755131-B3C76BDE-DEFF-42A9-A78F-043E0244FD0F Q33871661-F0E8FCA6-CE59-4EC3-B9E2-4BA7CC1B2CDC Q34017200-1140A8B2-FED3-42F9-A7B1-100B122BBFA0 Q34177457-8D6A1EEF-6F72-4061-AD4A-E2A6A1A005AB Q34198230-F8622784-E233-4F51-8484-194986CF4E22 Q34369305-3DC68872-8386-4A99-B4A9-4277DE4DE431 Q34400375-8CCD3FD3-4EE1-40EE-BA0E-D3547B523183 Q34429244-6B8C5CAD-1F1D-45D0-97E7-1F01075B0413 Q34433638-A837C11A-7C03-439B-AC79-521A3BBDA83A Q34687185-D1C6855C-71EC-4C5A-B80E-CFD949ABBD7D Q34997752-CE192890-C566-4F4B-9100-5C74883FED1A Q35268601-8CE753A2-4389-4C02-8D45-B3F25907EFA1 Q35750986-E000C242-9482-4C64-AF9D-18985BEC9C88 Q35946029-1393E95D-53A6-4B26-B07A-CCC0558F1E00 Q36035654-5CA5D296-57D2-4272-B03C-E1FE4B02F7F8 Q36041152-69A18925-5674-4501-8B0D-BD7AD3EE1809 Q36206887-C6FF4A87-56D5-4490-9E63-1983FA6F468E Q36289908-E708F650-E88B-47C9-A595-8B0CC15B725D Q36291341-6A214C7F-69EB-4BF3-98B9-6DB63B64C4F6 Q36377949-11A9A8B6-CCD3-4278-97E4-2279B0B0F93D Q36491662-88D6FD85-AF12-4D61-8B17-4CE6125CD5E5 Q36497118-884C0645-D675-48EA-ADBD-5EDB3EBE2D06 Q36508082-A2B10E2D-2B14-4E7B-AC53-6AF2814F10E6 Q36580595-61DB8EEE-1439-45AE-9E66-EEABC44A0C50 Q36606882-7DE405E5-AF44-4A08-B83A-240BC53DA863 Q36729573-204A9EFA-F78A-4E35-9FF7-4210B676A57B Q36782447-3B93D6D7-95B5-448F-A18C-8044D0BFD324 Q36802115-D74CD32F-D7C3-4EDB-86F6-BC6DE6FBE04A Q36913097-3D2DC43A-0F77-4D0F-8E67-B3CA4DABA9E4 Q37042365-9094A49A-0F51-42FB-B397-640A4CE0A730 Q37117878-126C066B-B941-4DB9-B296-DB20917B30BF Q37179559-0F48DB0C-8D67-4C67-853D-649429E7C586 Q37235449-148C0294-A6A7-4F80-A988-4D06D70BA95E

P2860

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

http://www.wikidata.org/entity/Q28361953

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Effect of pravastatin on survi ...... A randomized controlled trial

@ast

Effect of pravastatin on survi ...... A randomized controlled trial

@en

Effect of pravastatin on survi ...... A randomized controlled trial

@nl

type

label

Effect of pravastatin on survi ...... A randomized controlled trial

@ast

Effect of pravastatin on survi ...... A randomized controlled trial

@en

Effect of pravastatin on survi ...... A randomized controlled trial

@nl

prefLabel

Effect of pravastatin on survi ...... A randomized controlled trial

@ast

Effect of pravastatin on survi ...... A randomized controlled trial

@en

Effect of pravastatin on survi ...... A randomized controlled trial

@nl

P1433

Q28361953-80C8DDAA-6889-4B3E-B84C-BEBEAC2776AC

P1476

Q28361953-56168A74-86CC-4F63-BD09-8DF8AA0CEF63

P2093

Q28361953-1B14EF0D-65A5-49E9-849A-AA62DD0DD70F

Q28361953-2466E702-3B48-4370-8756-10CB739BA45A

Q28361953-3B77BDE1-D305-4DB1-8BC4-1F6026F2386A

Q28361953-3D7073A7-8B89-499D-8653-284DC5A6E7D3

Q28361953-3EE85733-19E9-46C2-B1BB-F5F9172B3D74

Q28361953-62A91648-F712-48C5-88B0-C599B5277166

Q28361953-9C34EE28-1026-477F-8384-F8EB6BF8B382

Q28361953-D99170BC-0D2E-4A45-8FFC-532A523550AF

Q28361953-DAD9C8C5-D889-41CB-851E-EDB0616C9DE2

Q28361953-DE541D7D-3DB7-408A-9EEC-0D9CBD9D5E94

P2860

Q28361953-0F91C129-F51D-4049-8F2C-5824168DE80A

Q28361953-17DFE3E6-DE96-4030-B369-D5D66DA55368

Q28361953-4F7D0C09-0EDB-4B31-84C7-846EC2763786

Q28361953-53ABBF03-D863-4D26-9A55-BE2FC109D242

Q28361953-7E7D4474-EEDA-4206-BF64-9F0A86EA807C

Q28361953-80A266ED-8FFF-4CAE-8E99-0A59C0127960

Q28361953-8697E40F-5D4A-4FF7-8D94-2CDF8E13C641

Q28361953-96B00E48-9E5A-4D63-A930-59B02B542148

Q28361953-983EA5A3-DA42-48AA-92A6-8A1826661B2D

Q28361953-BFE54BB1-22D9-436F-BF4E-F230673091E2

P2888

Q28361953-254A69E5-F16B-46F9-8BD6-F3E4C5A5DC76

P304

Q28361953-ED65C6D5-ED33-41A7-A185-E328BAF4668B

P31

Q28361953-E36E52EC-3E44-4CE7-A1E8-7CD87188A0BE

P356

Q28361953-238835BD-EF1B-488C-BC97-0345875905C5

P407

Q28361953-A08E2F21-309C-460F-A0D1-E1D791F02005

P433

Q28361953-1167A792-B487-41F9-BC0D-73629FB77D91

P478

Q28361953-9BA58ADD-7AC5-46FC-AF01-218D73A0E54A

P577

Q28361953-3D808865-EB2A-4936-9606-3F9C748493FF

P5875

Q28361953-76237A5C-925D-48B1-B829-030E89EAEA93

P6179

Q28361953-C313702B-7B99-4CAC-93C9-A43BDA4D1A88

P698

Q28361953-EF2C46B8-53CC-490C-B26F-867D5D2476EF

P921

Q28361953-5BD9917B-6E6E-4F48-A98D-86393922421A

P932

Q28361953-8BAC30A3-F79F-472E-B79C-D8C6CE16B1D4

P356

P1433

British Journal of Cancer

P1476

Effect of pravastatin on survi ...... A randomized controlled trial

@en

P2093

E Yamasaki

http://www.w3.org/2001/XMLSchema#string

M Inada

http://www.w3.org/2001/XMLSchema#string

N Ito

http://www.w3.org/2001/XMLSchema#string

S Kawata

http://www.w3.org/2001/XMLSchema#string

S Noda

http://www.w3.org/2001/XMLSchema#string

S Tamura

http://www.w3.org/2001/XMLSchema#string

T Nagase

http://www.w3.org/2001/XMLSchema#string

Y Imai

http://www.w3.org/2001/XMLSchema#string

Y Inui

http://www.w3.org/2001/XMLSchema#string

Y Matsuda

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

Regulation of the mevalonate pathway

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

Hepatocellular carcinoma: recent progress.

Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor.

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience.

Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells.

P2888

P304

886-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2000.1716

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12048276

http://www.w3.org/2001/XMLSchema#string

P6179

1009833802

http://www.w3.org/2001/XMLSchema#string

P698

11286466

http://www.w3.org/2001/XMLSchema#string

P921

P932

2363838

http://www.w3.org/2001/XMLSchema#string